Canine cognitive dysfunction: Available treatments

Authors

  • Bárbara de Paula Arrais ALENCAR Universidade de Fortaleza (UNIFOR)
  • Priscila de Alencar ALVES Universidade de Fortaleza (UNIFOR)
  • Roberta Nogueira CHAVES Universidade de Fortaleza (UNIFOR)

Keywords:

Dog, Cognitive deficit, Therapeutic, Physiopathogeny

Abstract

Canine cognitive dysfunction (CCD) is a disease that causes physiological and behavioral changes in elderly dogs and presents a physiopathogeny similar to Alzheimer's disease (AD), which affects humans. Clinical signs are represented by the acronym DISHA (disorientation, changes in interaction with people/animals, changes in the sleep-wake cycle, learning/memory failure, and altered activity level). The main form of diagnosis of illness is based on a questionnaire answered by the tutor, related to the animal behavior. The treatment is multimodal, basically consisting of drug use, changes in the diet, and environmental and mental enrichment. The drugs used are of various pharmacological classes and act directly on substances related to the physiopathogeny of CCD, besides attenuating some clinical signs of the disease.This drug action is enhanced with the addition of specific foods, enrichment of the environment where the animal lives and mental stimulation, mainly through tours. The union of all these treatment modalities helps to improve the welfare of the affected animal. As the disease has no cure, the treatment is long and it is often not possible to visualize evident improvement in the animal. In this way, some tutors opt for euthanasia. Despite being frequent in elderly dogs and there is a broad literature on CCD,there is no specific therapeutic protocol. There are several treatments available in isolation in the literature, causing veterinary clinicians find it difficult to locate a compilation of information from a single source.

References

ALFREDO, A.F.; FERRARIN, D.A.; BRITO, R.S.A.; FARIA, J.L.M.; VERARDI, A.D.; MUELLER, E.N. Avaliação de um suplemento para animais idosos no tratamento de cães com sinais clínicos sugestivos da síndrome da disfunção cognitiva canina. Medicina Veterinária, UFRPE, v.14, n.2, p.85-91, 2020.

ANDRADE, S.F. Manual de terapêutica veterinária – consulta rápida. 1ª ed., Rio de Janeiro: Editora Roca, 2017. 456p.

BARREIROS, A.L.B.S.; DAVID, J.M.; DAVID, J.P. Estresse oxidativo: relação entre geração de espécies reativas e defesa do organismo. Química Nova, v.29, n.1, p.113-123, 2006.

BELLOWS, J.; COLITZ, C.M.H.; DARISTOTLE, L.; INGRAM, D.K.; LEPINE, A.; MARKS, S.L.; SANDERSON, S.L.; TOMLINSON, J.; ZHANG, J. Common physical and functional changes associated with aging in dogs. JAVMA, v.246, n.1, p.67-75, 2015.

BENZAL, A.; RODRÍGUEZ, A. Recent developments in Canine Cognitive Dysfunction Syndrome. Pet Behaviour Science, v.1, p.47-59, 2016.

BOSCH, M.N.; PUGLIESE, M.; GIMENO-BAYÓN, J.; RODRÍGUEZ, M.J.; MAHY, N. Dogs with cognitive dysfunction syndrome: a natural model of Alzheimer's disease. Current Alzheimer Research, v.9, p.298-314, 2012.

BRIONES, F.S.; CÁCERES, T.D.; JARPA, M.F. Detección de b-amiloide, proteína TAU hiperfosforilada y ubiquitina por técnica de inmunohistoquímica en cerebros de caninos mayores de 10 años. International Journal of Morphology, v.28, n.4, p.1255-1261, 2010.

CALDWELL, F. How to nurse the geriatric patient. The Veterinary Nurse, v.11, n.3, p.147-151, 2020.

CORY, J. Identification and management of cognitive decline in companion animals and the comparisons with Alzheimer disease: A review. Journal of Veterinary Behavior, v.8, n.4, p.291-301, 2013.

COTMAN, C.W.; HEAD, E. The canine (dog) model of human aging and disease: dietary, environmental and immunotherapy approaches. Journal of Alzheimer's Disease, v.15, n.4, p.685-707, 2008.

DENENBERG, S.; LIEBEL, F.X.; ROSE, J. Behavioural and medical differentials of cognitive decline and dementia in dogs and cats. Switzerland: 1ª ed., Springer, p.129-143, 2017.

DEWEY, C.W. (org.). Neurologia de cães e gatos: guia prático. 1ª ed., São Paulo: Roca, 2006. 352p.

DRUCE, K. Canine cognitive dysfunction - recognition and treatment. Veterinary Nursing Journal, v.29, n.8, p.268-270, 2015.

FAGUNDES, T.; MAZZOTTI G. Disfunção cognitiva canina. Medvep - Revista Científica de Medicina Veterinária. v.12, n.45, p.1-9, 2016.

FOLLMER, C.; BEZERRA NETO, H.J.C. Fármacos multifuncionais: monoamina oxidase e α-sinucleína como alvos terapêuticos na doença de Parkinson. Química Nova, v.36, n.2, p.306-313, 2013.

FRY, M. Cognitive dysfunction in older dogs and cats: the role of the veterinary nurse in screening. The Veterinary Nurse, v.6, n.5, p.266-274, 2015.

GALLEGO, D.; FIGUEROA, J.R.; OROZCO, C.S. Síndrome de disfunción cognitiva de perros geriátricos. Revista MVZ Córdoba, v.15, n.3, p.2252-2262, 2010.

GONZÁLEZ-MARTÍNEZ, Á.; ROSADO, B.; GARCÍA-BELENGUER, S.; SUÁREZ, M. Síndrome de disfunción cognitiva en el perro geriátrico. Clínica Veterinaria de Pequeños Animales, v.32, n.4, p.159-167, 2012.

GUPTA, R.C.; SRIVASTANA, A.; LALL, R. Nutraceuticals in Veterinary Medicine. Switzerland: 1ª ed., Springer, 2019. 877p.

HAND, M.S.; THATCHER, C.D.; REMILLARD, R.L.; ROUDEBUSH, P.; NOVOTNY, B.J. Small Animal Clinical Nutrition. Topeka, EUA: Mark Morris Institute, p.715-730, 2010.

HEAD, E.; ROFINA, J.; ZICKER, S. Oxidative stress, aging, and central nervous system disease in the canine model of human brain aging. 5ª ed., Veterinary Clinics of North America: Small Animal Practice, v.38, 2008. 1314p.

HEAD, E. Neurobiology of the aging dog. AGE, v.33, n.3, p.485-496, 2011.

HEAD, E. A canine model of human aging and Alzheimer's disease. Biochimica et Biophysica Acta, v.1832, n.9, p.1384-1389, 2013.

LAFLAMME, D.P. Nutriotinal care for aging cats and dogs. Veterinary Clinics of North America: Small Animal Practice, v.42, n.4, p.769-791, 2012.

LANDSBERG, G.M. Therapeutic agents for the treatment of cognitive dysfunction syndrome in senior dogs. Progress in Neuro-Psychopharmacology & Biological Psychiatry, v.29, p.471-479, 2005.

LANDSBERG, G.M.; DEPORTER, T.; ARAUJO, J.A. Clinical signs and management of anxiety, sleeplessness, and cognitive dysfunction in the Senior Pet. Veterinary Clinics of Small Animal, v.41, n.3, p.565-590, 2011.

LANDSBERG, G.M.; NICHOL, J.; ARAUJO, J.A. Cognitive dysfunction syndrome: a disease of canine and feline brain aging. Veterinary Clinics of Small Animal, v.42, n.4, p.749-768, 2012.

MANTECA, X. Nutrition and behavior in senior dogs. Topics in Companion Animal Medicine, v.26, n.1, p.33-36, 2011.

MAY, K.A.; LAFLAMME, D.P. Nutrition and the aging brain of dogs and cats. JAVMA, v.255, n.11, p.1245-1254, 2019.

MIHEVC, S.; MAJDIC, G. Canine Cognitive Dysfunction and Alzheimer’s Disease – Two Facets of the Same Disease? Frontiers in Neuroscience, v.13, n.604, p.1-18, 2019.

NESIC, S.; KUKOLJ, V.; MARINKOVIC, D.; VUCICEVIC, I.; JOVANOVIC, M. Histological and immunohistochemical characteristics of cerebral amyloid angiopathy in elderly dogs. Veterinary Quarterly, v.37, n.1, p.1-7, 2016.

NEVES, I.; TUDUTY, E.; COSTA, R. Fármacos utilizados no tratamento das afecções neurológicas de cães e gatos. Semina: Ciências Agrárias. v.31, n.3, p.745-766, 2010.

OKUDA, M.; FUJITA, Y.; KATSUBE, T.; TABATA, H.; YOSHINO, K.; HASHIMOTO, M.; SUGIMOTO, H. Highly water pressurized brown rice improves cognitive dysfunction in senescence-accelerated mouse prone 8 and reduces amyloid beta in the brain. BMC Complementary Medicine and Therapies, v.18, n.1, p.1-8, 2018.

OLIVEIRA, H.; MARCASSO R.; ARIAS M. Doenças cerebrais no cão idoso. Medvep - Revista Científica de Medicina Veterinária - Pequenos Animais. v.12, n.45, p1-15, 2016.

PAN, Y. Enhacing brain functions in senior dogs: a new nutrutional approach. Topics in Companion Animal Medicine, v.26, n.1, p.10-16, 2011.

PANEK, W.K.; MURDOCH, D.M.; GRUEN, M.E.; MOWAT, F.M.; MAREK, R.D.; OLBY, N.J. Plasma amyloid beta concentrations in aged and cognitively impaired pet dogs. Molecular Neurobiology, v.58, n.2, p.483-489, 2021.

PINEDA, S.; OLIVARES, A.; MAS, B.; IBAÑEZ, M. Cognitive dysfunction syndrome: updated behavioral and clinical evaluations as a tool to evaluate the well-being of aging dogs. Archivos de Medicina Veterinaria, v.46, n.1, p.1-12, 2014.

PIPAN, M.Z.; MIHEVC, S.P.; STRBENC, M.; KOSAK, U.; ILIC, I.G.; TRONTELJ, J. ZAKELJ, S.; GOBEC, S.; PAVLIN, D.; MAJDIC, G. Treatment of canine cognitive dysfunction with novel butytylcholinesterase inhibitor. Scientific reports, v.11, n.18098, p.1-10, 2021.

SALVIN, E.H.; McGREEVY, P.D.; SACHDEV, P.S.; VALENZUELA, M.J. The canine cognitive dysfunction rating scale (CCDR): a data-driven and ecologically relevant assessment tool. The Veterinary Journal, v.188, n.3, p.331-336, 2011.

SCHIMANSKI, L.; PASCOLI, A.; FILHO, N.; FERREIRA, M. Síndrome da disfunção cognitiva em cães – do diagnóstico ao tratamento. Investigação, v.18, n.6, p.28-34, 2019.

SILVA, B.; GENEIDING, B.; LUCIOLI, J.; TESSER, J.; BASILIO, J.E.O.G. Síndrome da disfunção cognitiva canina: revisão de literatura. Revista Acadêmica: Ciência Animal, v.16, n.1, p.1-8, 2018.

SOUSA, A.; SOUZA, L. Síndrome da disfunção cognitiva em cães – revisão de literatura. Ciência Veterinária UniFil, v.1, n.3, p.121-137, 2018.

SPINOSA, H.S.; GÓRNIAK, S.L.; BERNARDI, M.M. Farmacologia aplicada à medicina veterinária. 6ª ed., Rio de Janeiro: Guanabara Koogan, 2019. 932p.

STELOW, L. Diagnosing behavior problems: a guide for pratitioners. Veterinary Clinics of North America: Small Animal Practice, v.48, n.3, p.339-350, 2018.

STURZA, A.; POPOIU, C.M.; IONICA, M.; DUICU, O.M.; OLARIU, S.; MUNTEAN, D.M.; BOIA, E.S. Monoamine oxidase-related vascular oxidative stress in diseases associated with inflammatory burden. Oxidative Medicine and Cellular Longevity, v.2019, n.1, p.1-8, 2019.

SUEDA, K.; CHO, J. Environmental enrichment for sênior dogs e cats. Clinician’s Brief, v.2017, n.1, p.15-18, 2017.

SZABÓ, D.; GEE, N.R.; MIKLÓSI, A. Natural or pathologic? Discrepancies in the study of behavioral and cognitive signs in aging family dogs. Journal of Veterinary Behavior, v.11, n.2, p.86-98, 2016.

VIANA, F.A.B. Guia terapêutico veterinário. 3ª ed., Lagoa Santa: Editora CEM, 2014. 560p.

VIKARTOVSKA, Z.; FARBAKOVA, J.; SMOLEK, T.; HANES, J.; ZILKA, N.; HORNAKOVA, L.; HUMENIK, F.; MALOVESKA, M.; HUDAKOVA, N.; CIZKOVA, D. Novel diagnostic tools for identifying cognitive impairment in dogs: behavior, biomarkers, and pathology. Frontiers in Veterinary Science, v.7, n.1144, p.1-13, 2021.

YOUSSEF, S.A.; CAPUCCHIO, M.T.; ROFINA, J.E.; CHAMBERS, J.K.; UCHIDA, K.; NAKAYAMA, H.; HEAD, E. Pathology of the aging brain in domestic and laboratory animals, and animal models of human neurodegenerative diseases. Veterinary Pathology, v.53, n.2, p.327-348, 2016.

Published

2022-11-17

How to Cite

ALENCAR, B. de P. A. .; ALVES, P. de . A. .; CHAVES, R. N. . Canine cognitive dysfunction: Available treatments. Ciência Animal, [S. l.], v. 32, n. 2, p. 110–122, 2022. Disponível em: https://revistas.uece.br/index.php/cienciaanimal/article/view/9479. Acesso em: 17 may. 2024.